Trial intelligence / Profile preview

Phase 3 double-blind comparison of TAK-438 vs AG-1749 in duodenal ulcer

jRCT2080221568Phase 3

Sponsor
Takeda
Start
Sep 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of vonoprazan in duodenal ulcer (2 arms), sponsored by Takeda.

02

Drugs

vonoprazan
03

Conditions

duodenal ulcer

Beyond the preview

Go deeper on jRCT2080221568.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080221568.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call